What is the cure rate of small cell lung cancer

What is the cure rate of small cell lung cancer? Many patients with small cell lung cancer have learned about the malignancy of this disease through various channels. When undergoing treatment, they will ask the doctor what the cure rate is. Today, let's take a look at the cure rate of small cell lung cancer:

The clinical characteristics of small cell lung cancer are: short tumor cell doubling time, rapid progression, often accompanied by endocrine abnormalities or carcinoid syndrome. Small cell lung cancer is more sensitive to chemotherapy, so chemotherapy can be considered, but chemotherapy alone has great side effects, often causing vomiting, hair loss, anorexia, decreased immunity and other symptoms. Improving immunity, strengthening physical fitness, and preventing recurrence and metastasis.

Small cell lung cancer is an undifferentiated cancer type of lung cancer, accounting for about 20-25% of lung cancer. Small cell lung cancer is divided into limited stage and extensive stage. Most small cell lung cancers are diagnosed in the extensive stage, and the limited stage accounts for up to 1/3. It is derived from the malignant transformation of lung Kulchitsky cells. WHO divides it into three types: oat cell type, intermediate cell type and mixed cell type. The disease is more common in men than in women; the site of onset is mostly large bronchi (central type).

What is the cure rate of small cell lung cancer? Small cell lung cancer is the fastest growing type of lung cancer cell and is very easy to spread and metastasize. However, whether it can be cured depends not only on the cell type, but also on how early it is discovered, whether surgery is possible, the patient's physical condition, mentality, economic conditions, etc. In general, the cure rate is uncertain with active treatment, and if it is not actively treated, it will only take a few months for small cells to develop to death.

Note: Although small cell lung cancer is relatively sensitive to radiotherapy and chemotherapy, it is also particularly prone to drug resistance. Early treatment is often more effective, but drug resistance will appear in the late stage. Small cell lung cancer causes more harm to patients, and patients must receive symptomatic treatment according to their own condition.